| Name | Title | Contact Details |
|---|
MedPoint is focused on innovative, high-value services. We are a global best-in-class company in our service areas. We work with clients on new approaches to training, education and communications that work in the real world of medicine.
Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.
Intrigma is a leader in medical scheduling solutions that deliver bottom-line impact to medical groups, hospitals and hospital systems.
Scimega Research Inc is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.